Enhancing Environmental Health Literacy and Practice for Healthcare Providers: An Innovative CME Series

提高医疗保健提供者的环境健康素养和实践:创新的 CME 系列

基本信息

  • 批准号:
    10525469
  • 负责人:
  • 金额:
    $ 25.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-19 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Ample evidence demonstrates that toxicants and other environmental exposures lead to both acute and chronic health conditions. This proposal is a direct outgrowth of our experience with a community heavily exposed to chemical toxicants. We have demonstrated significant adverse health outcomes associated with this exposure. However, many community members report a lack of knowledge and skills among their healthcare providers to address their exposure- related health risks. These reports are consistent with documentation that healthcare providers (HCPs) rarely address environmental concerns with patients and report a lack of knowledge and ability regarding these patient concerns. These knowledge and practice gaps are not surprising since few nursing or medical schools include environmental health training in their curricula. As such, there is a critical need to expand healthcare provider training in environmental health. To address this critical need, we will develop an innovative continuing medical education (CME) series. The innovation is two-fold. First, we will partner with impacted community members to develop patient-centered and community-centered material, focusing on lived experiences of community members and their healthcare providers. Second, we will utilize interactive and engaging tools to facilitate learning and integration into practice. The series will be titled “Understanding and mitigating the impact of environmental chemicals on the health of your patients.” We will design CME learning experiences that are both evidence-based and informed by years of online teaching experience. To ensure the relevance of the content to patients and HCPs, members of communities affected by endocrine-disrupting chemicals and HCPs in these communities will be involved throughout the entire cycle of course design, development, piloting, and evaluation. Additionally, their voices and stories will be featured in images, audio, and video assets in the course. This Phase One SBIR grant will develop and design the first module of the CME series titled “How Endocrine Disrupting Chemicals from the Environment act as Uncontrolled Medicine in Your Patients.” We will also develop pocket guides, job aids, and infographics that can be easily downloaded to assist in translating learning to clinical practice. Pilot testing for usability and scalability will also be completed. This project will generate an engaging, easily-accessible, informative course to introduce HCPs to important environmental health concepts related to endocrine-disrupting chemicals, which will provide HCPs with the ability to address patients’ health concerns. If successful, this project will improve health outcomes and save lives by giving healthcare providers the knowledge and tools to protect their patients from preventable impacts of environmental exposures to endocrine-disrupting chemicals.
充足的证据表明,有毒物质和其他环境暴露会导致急性和慢性健康 状况。该提案是我们在严重接触化学物质的社区中积累的经验的直接产物 有毒物质。我们已经证明了与这种暴露相关的严重不良健康后果。然而,许多 社区成员报告说,他们的医疗保健提供者缺乏解决他们接触问题的知识和技能—— 相关的健康风险。这些报告与医疗保健提供者 (HCP) 很少提及的文档一致 患者对环境的担忧,并报告缺乏有关这些患者担忧的知识和能力。这些 知识和实践的差距并不奇怪,因为很少有护理或医学院包括环境健康课程 他们的课程培训。因此,迫切需要扩大医疗保健提供者在环境健康方面的培训。 为了满足这一迫切需求,我们将开发创新的继续医学教育 (CME) 系列。创新之处在于 双重。首先,我们将与受影响的社区成员合作,制定以患者为中心和以社区为中心的计划 材料,重点关注社区成员及其医疗保健提供者的生活经历。其次,我们将利用 交互式和引人入胜的工具,以促进学习和融入实践。该系列的标题是“理解 并减轻环境化学物质对患者健康的影响。”我们将设计CME学习 这些经验既基于证据,又来自多年的在线教学经验。为了确保相关性 向患者和 HCP、受内分泌干扰化学品影响的社区成员以及这些领域的 HCP 提供的内容 社区将参与课程设计、开发、试点和评估的整个周期。 此外,他们的声音和故事将出现在课程的图像、音频和视频资产中。本期第一阶段 SBIR 赠款将开发和设计 CME 系列的第一个模块,题为“内分泌干扰物如何从 环境对患者来说就像不受控制的药物。”我们还将开发袖珍指南、工作辅助工具和 可以轻松下载的信息图表,以帮助将学习转化为临床实践。可用性试点测试 并且可扩展性也将完成。该项目将生成一门引人入胜、易于访问、信息丰富的课程, 向 HCP 介绍与内分泌干扰化学品相关的重要环境健康概念,这将提供 HCP 有能力解决患者的健康问题。如果成功,该项目将改善健康状况并 通过向医疗保健提供者提供知识和工具来保护患者免受可预防的影响,从而拯救生命 环境暴露于内分泌干扰化学物质。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adarsh Char其他文献

Adarsh Char的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 25.94万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了